Pioglar 7.5 Tablet
By Pioglar
10 Tablet in a Strip

Composition
Pioglitazone(7.5mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
April, 2027

liver
When taking Pioglar 7.5 Tablet, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment, so consulting your doctor before use is crucial. Avoid using Pioglar 7.5 Tablet if you have severe liver disease to prevent any potential complications. Remember to discuss your liver health history with your healthcare provider before starting this medication.

kidney
Pioglar 7.5 Tablet is safe for patients with kidney disease. Your doctor may adjust the dose, especially if you have a history of kidney conditions. No dose adjustment of Pioglar 7.5 Tablet is recommended.

alcohol
For your safety, avoid consuming alcohol with Pioglar 7.5 Tablet to prevent potential side effects.

driving
Pioglar 7.5 Tablet typically does not impact your driving ability. However, be cautious if you notice any changes in your vision while using Piozar 7.5 Tablet 10's.

pregnancy
Pioglar 7.5 Tablet is not recommended during pregnancy. Limited human studies and animal research suggest potential harm to the developing baby. Your doctor will evaluate the benefits versus risks before prescribing. Consult your doctor before using Pioglar 7.5 Tablet during pregnancy.

breastfeeding
During breastfeeding, caution is advised when using Pioglar 7.5 Tablet. It is recommended to wait until the mother's treatment is finished and the drug clears from her body. Monitor the baby's blood sugar while the mother is on Pioglar 7.5 Tablet.
Habit Forming | No |
Chemical Class | Thiazolidinedione Derivative |
Therapeutic Class | ANTI DIABETIC |
Action Class | Thiazolidinedione(PPAR gamma agonist) |
₹66.5
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024